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ABSTRACT
A novel RNA polymerase I (RPI) driven reporter gene
has been used to investigate the in vivo role of the
architectural ribosomal transcription factor UBF in
gene activation and species specificity. It is shown that
the level of UBF overexpression in NIH3T3 cells leads
to a proportionate increase in the activities of both
reporter and endogenous ribosomal genes. Further,
co-expression of UBF antisense RNA suppresses
reporter gene expression. Thus, UBF is limiting for
ribosomal transcription in vivo and represents a
potential endogenous ribosomal gene regulator. In
contrast to some in vitro studies, in vivo, the mammalian
and Xenopus forms of UBF1 show an equal ability to
activate a mouse RPI promoter. This activity is severely
impaired in mutants compromised for either dimerization
or DNA binding. Similarly, the natural UBF2 splice
variant shows a severely impaired capacity to activate
RPI transcription. The data strongly suggest that UBF
predominantly regulates ribosomal transcription by
binding to and activating the ribosomal genes, but
does not eliminate a possible secondary role in
titrating ribosomal gene repressors such as Rb.
Consistent with the DNA folding ability and cellular
abundance of the UBF, we suggest that the protein may
regulate a structural transition between the potentially
active and active chromatin states.
INTRODUCTION
The ribosomal genes encoding the 18S, 5.8S and 28S ribosomal
RNAs (rRNA) are exclusively transcribed by a dedicated
polymerase, RNA polymerase I (RPI). These genes are typically
responsible for 35% of total cellular RNA production while their
products constitute 80% of the total mass of cellular RNA. It is
known that regulation of rRNA transcription is the key factor in
regulating ribosome biogenesis (reviewed in 1–3). Thus, ribosomal
transcription is a major factor in determining cell growth rate. The
ribosomal genes are typically present in animal genomes in
several hundreds of copies and, with certain exceptions, are
organized in simple tandem arrays. Although as early as the
1970s, regulation of the ribosomal genes had been shown to occur
at two distinct levels (4,5): (i) the number of transcripts per gene
and (ii) the number of active genes, the mechanisms underlying
this regulation still remain a question. The initiation rate per
ribosomal gene is probably regulated at the level of RPI (6–10;
reviewed in 1,2). Various experiments have identified the levels
of initiation competent RPI to be subject to regulation, and it has
been shown that this is probably due to changes in certain RPI
associated factors. However, the molecular nature of these factors
has to date remained unidentified. As for the mechanism which
determines active gene number, we are still lacking a good
candidate to mediate this level of regulation.
In vitro, RPI initiation requires the polymerase and a specific
TBP-complex, SL-1 (1–3,10,11). Initiation is, however, strongly
enhanced by the HMG-box factor UBF (12,13).
Indeed, in vitro footprinting on the human rDNA promoter has
shown that UBF plays an essential role in facilitating the
interaction of SL-1 with the RPI promoter (14). In other
mammalian systems it has been shown that UBF is essential in
vitro at low template concentration and that it allows the
activation of a histone bound template (15). Thus, binding of UBF
to the ribosomal genes could represent a key step in gene
activation in vivo. However, despite extensive in vitro studies of
the role of UBF in ribosomal transcription, almost nothing has
been done to date to relate these findings to the situation in vivo.
RPI transcription is, to a great extent, species-specific. Rodent
SL-1 cannot replace human SL-1 for in vitro transcription of the
corresponding ribosomal promoters (1–3,12 and references
therein). UBF has also been demonstrated to contribute to the
species specificity of ribosomal transcription. While human and
rodent UBF are completely interchangeable (16), Xenopus UBF
can only to some degree replace the mammalian UBF in
mammalian in vitro transcription assays, and mammalian UBF
was inactive in the Xenopus in vitro transcription system (16–18).
This species specificity has been ascribed to the absence in xUBF
of the mammalian HMG-box 4 DNA binding domain (19–21). In
both mammals and Xenopus, UBF has been found to be subject
to differential splicing. In mammals the UBF2 isoform is missing
the HMG-box2 DNA binding domain. It has been suggested from
in vitro studies that this isoform is significantly compromised in
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its ability to bind DNA and activate transcription (22,23).
However, the significance of these findings to the in vivo situation
are not known.
Here we have compared the capacities of various UBF isoforms
including rodent UBF, Xenopus UBF and UBF mutants compro-
mised for dimerization, to activate ribosomal transcription in
mouse cells. We demonstrate that overexpression of UBF1 is
sufficient to significantly increase accurate transcription from
both a cotransfected rodent rDNA promoter construct and also the
endogenous ribosomal genes in NIH3T3 cells. rUBF2 was one
third as active as rUBF1 in transactivating the same promoter. A
construct directing expression of antisense UBF inhibited basal
pSMECAT activity. Interestingly, overexpression of Xenopus
UBF (xUBF) but not sxUBF, a deletion mutant of xUBF lacking
the dimerization domain, was just as efficient as rUBF in
stimulating rodent rDNA transcription. At the same time, a
Xenopus rDNA promoter construct was inactive in NIH3T3 cells
and was not stimulated by the overexpression of either xUBF or
rUBF. These results argue that in vivo the activity of UBF is not
species-specific and that the appropriate UBF cannot abrogate the
need for the homologous form of SL-1. Together these data
suggest that (i) altering the cellular content of UBF is sufficient
to modulate rRNA synthesis and (ii) the observed increase in
rDNA transcription following overexpression of UBF results
from a direct action of UBF at the level of RPI transcription that
is dependent on its ability to dimerize.
MATERIALS AND METHODS
Cell culture
Monolayer cultures of NIH3T3 cells were maintained in Dulbecco’s
modified Eagle’s medium (DMEM, Gibco BRL) supplemented
with 10% fetal bovine serum (FBS) at 37C in a 5% CO2
atmosphere. For transfections, the cells were plated on 60 mm
dishes at 0.3 × 106 cells/dish 24 h before transfection.
Construction of rDNA transcription reporter constructs
(Fig. 1A)
To construct pSMECAT and pSMECAT-7, the murine ribosomal
promoter fragment (24) containing nucleotides –152 to +60, relative
to the site of transcription initiation (+1), was subcloned by PCR
using the primers 5′-GAATTCTGAGGTCCGGTTCTTTTCG-3′
and 5′-GAATTCCTTAAATCGAAAGGGTCTC-3′. Amplification
of this subclone with the primers 5′-GAATTCTGAGGTCCGG-
TTCTTTTCG-3′ and 5′-CCTTCCAGGTATTCTCTG-3′ resulted
in a 150 bp fragment containing a G to A mutation of base –7 within
the core promoter. The mutated fragment was used in combination
with the primer 5′-GAATTCCTTAAATCGAAAGGGTCTC-3′ to
generate a complete mutant promoter, i.e. –150 to +64. Both the
mutant and the wild-type mouse promoters were then inserted
into the EcoRI site of pBSECAT (25), which contains the
encephalomyocarditis virus (EMCV) internal ribosome entry site
(IRES) upstream of the Escherichia coli chloramphenicol acetyl
transferase gene. pXMECAT and piXMECAT were similarly
constructed using the primers 5′-GAATTCTCCCGCGGAGGC-
CCCGAT-3′ and 5′-GGAATTCGAGGCGGGAAACGCCCCG-
GTC-3′ to amplify sequences –152 to +60 of the Xenopus laevis
ribosomal promoter (26).
Construction of UBF expression constructs
A number of full-length and mutant rat and Xenopus UBF
expression constructs were used in this study (Fig. 1B). pCMV-
rUBF1 was generated by PCR from the rat UBF1 cDNA (27)
using a primer containing a BamHI linker followed by the first
20 nucleotides of the 5′ end of the UBF1 coding region, and a
second primer complementary to the last 19 nucleotides of the
UBF1 cDNA followed by an EcoRI linker. pCMV-FLAG-rUBF1
and pCMV-FLU-rUBF1 were constructed using the same 3′
primer as used for pCMV-rUBF1, however the 5′ primers
contained an additional 24 and 28 nucleotides coding for the
FLAG (IBI) or FLU (HA) epitopes, respectively. The tags were
inserted in frame, between the start ATG and second codon of
UBF1 cDNA. After PCR amplification, the products were cloned
into the mammalian expression vector pCDNA3 (Invitrogen).
This vector drives expression of UBF1 under the control of the
cytomegalovirus (CMV) promoter. The orientations of the inserts
were confirmed by sequencing and restriction endonuclease
mapping. pGAL4-rUBF1 and pGal4-rUBF2 were constructed by
inserting the DNA-binding domain of Gal4 (amino acids 1–92;
28) in frame upstream, in place of the initiation codons of UBF1
and UBF2. PCMV-r/xUBF1 encodes a chimeric rUBF in which
the mammalian-specific HMG-box 4 was replaced with the
equivalent region from xUBF1. This plasmid was constructed
from pCMV-FLAG-rUBF1 by precisely replacing the rUBF1
coding region for amino acids 363–479 with the equivalent, but
shorter, region from xUBF1. Silent mutations were first introduced
into the rUBF1 coding region to create XhoI and HindIII sites
bracketing the region to be replaced. The intervening rUBF1
fragment was then replaced by a PCR product amplified from the
xUBF1 cDNA (21,29) using primers 5′-CTCGAGAATCTCCCA-
GAAGAG-3′ and 5′-GGGTCTCTGGAAGCTTAGCCCTC-3′.
pCMV-FLU-XUBF1 was constructed in a similar way starting
from the xUBF1 cDNA (21,29) incorporating an ATG followed by
a FLU (HA) epitope coding segment in place of the natural ATG
(pCMV-xUBF1) or of the codon for arginine 97 (pCMV-sxUBF1).
Transfection and CAT/β-galactosidase assays
NIH3T3 cells were cotransfected in the presence of OptiMEM
(Gibco BRL) with the indicated constructs, (0.5–2 µg/60 mm
dish) and pSV40-βGal (0.5 µg/60 mm dish) (Promega Corp.)
using Lipofectamine (Gibco BRL). An appropriate amount of the
basic vector, pCDNA3, was included in the transfection media so
that all cells were exposed to the same total amount of DNA. Five
hours after transfection, the culture media was replaced with fresh
DMEM/10% FBS. Twenty-four hours after transfection the cells
were harvested, lysates prepared as described (30) and frozen at
–80C until assayed for either chloramphenicol acetyl transferase
(CAT) or β-galactosidase activity (βGal) (30). The results of the
CAT assays were normalized by the results of the β-galactosidase
assays to correct for variations in the efficiency of transfection.
Typical transfection efficiency, as assayed by an in situ β-galacto-
sidase assay (Promega Corp.), was ∼40%.
S1 analysis
The transcript from pSMECAT was mapped using a double
stranded probe extending from –150, the upstream boundary of
the mouse RPI promoter, to +207, within the EMCV IRES
sequence (31). The probe was 5′-32P-labeled at +207 using T4
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Figure 1. Reporter constructs for 45S rDNA transcription and characterization
of UBF1 expression plasmids. (A) Schematic representation of the 45S rDNA
reporter constructs: pSMECAT, mouse rDNA promoter reporter construct;
pSMECAT-7; mouse pXECAT; and piXECAT. (B) Schematic representation of
the UBF1 and UBF 2 expression constructs: pCMV-rUBF1, full-length rat
UBF1; pCMV-rUBF440-, nucleotides 1–440 of rat UBF1 in the antisense
orientation; pCMV-FLAG-rUBF1, full-length rat UBF1 tagged with the FLAG
epitope; pCMV-FLU-rUBF1, full-length rat UBF1 tagged with the FLU
epitope; pSV40-GAL4-rUBF1, full-length rat UBF1 tagged with the GAL4
DNA-binding domain; pSV40-GAL4-rUBF2, full-length rat UBF2 tagged
with the GAL4 DNA-binding domain; pCMV-FLAG-r/xUBF, rat–Xenopus
chimeric construct tagged with the FLAG epitope; pCMV-FLU-xUBF,
full-length Xenopus UBF1 tagged with the FLU epitope; pCMV-FLU-sxUBF1,
Xenopus UBF1 containing a deletion in the NH2-terminal dimerization domain
tagged with the FLU epitope. The relevant segments of each of the vectors are
indicated and a complete description of each construct is given in Materials and
Methods. CMV, cytomegalovirus promoter. SV40, simian virus promoter.
(C) Twelve hours after transfection with pCMV (lane 1, 2 µg), pCMV-rUBF1
(lane 2, 2 µg) or pCMV-FLAG-rUBF1 (lanes 3–5: 0.5, 1 and 2 µg), nuclear
proteins were isolated from NIH3T3 fibroblasts, fractionated by SDS–PAGE,
and blotted to nylon membranes. Wild-type, recombinant authentic and
recombinant FLAG-Tagged UBF was detected with the polyclonal anti-UBF
antibody (upper panel) and a monoclonal antibody to the FLAG epitope (lower
panel) as described in Materials and Methods.
kinase, denatured and hybridized at 48C in 80% formamide with
32 µg of total RNA isolated from control NIH3T3 cells or cells
cotransfected with pSMECAT and pCMV-rUBF1. The hybrid
was characterized on 8% denaturing acrylamide gels in 90 mM
Tris-borate, 2.5 mM EDTA, 8 M urea. The size of the protected
fragment was determined by comparison with the mobility of the
RsaI restricted S1 probe and with HpaII restricted pBR322.
Western analysis
NIH3T3 cells were released from the plates by treatment with
0.25% trypsin–EDTA. The cell pellets were washed once with
ice-cold PBS, resuspended in 1 ml of EBC buffer (50 mM
Tris–HCl, pH 8.0, 150 mM NaCl, 0.5% NP-40, 100 µl/ml
aprotinin, 100 µM benzamidine, 10 µM leupeptin), and incubated
on ice for 20 min. The cells were broken by vortexing, clarified
by centrifugation (10 000 g for 15 min) and the supernatant stored
at –70oC. Protein and DNA determinations were performed as
described (32). Western blots with a polyclonal anti-UBF, a
monoclonal anti-flag M2 antibody (cat no. IB13026/6D1311, IBI)
and a monoclonal anti-Flu antibody (Boehringer Mannheim) were
carried out as described previously (11–13)
Nuclear run-on transcription
Transcription from the rDNA promoter in isolated nuclei was
measured by the hybridization of in vitro synthesized, 32P-labeled
run-on transcripts to a 45S rDNA clone as described previously (32).
Coimmunoprecipitation
Coimmunoprecipitation was performed at 4C as described
previously (33). Whole cell extracts were pre-cleared by incubating
for 30 min with protein A-agarose beads (pre-washed with PBS).
The beads were removed by gentle centrifugation for 5 s, and the
pre-cleared extracts were incubated with 2 µg of anti-UBF
antibody and tumbled for 2 h. Subsequently, 25 µl of washed
protein A agarose beads were added and the sample tumbled for
an additional 2 h. The beads were washed three times in PBS
containing 0.5% NP-40, resuspended in 50 µl of Laemmli
SDS–PAGE sample buffer and incubated at 95C for 10 min. The
immunoprecipitated proteins were resolved on SDS–PAGE and
transferred to Immobilon-P for western blot analysis. For FLAG
immunopurification, whole cell extracts were incubated with
25 µl of anti-FLAG resin (IBI) and tumbled for 2 h. The beads
were washed three times in PBS containing 0.05% NP-40, 200 mM
NaCl and resuspended in 50 µl of PBS containing FLAG peptide
(0.5 mg/ml). After incubation for 10 min on ice, the samples were
centrifuged for 10 s and the supernatant removed and heated at
95C for 10 min with 10 µl of 5× Laemmli SDS–PAGE sample
buffer. The immunoprecipitated proteins were resolved on SDS–
PAGE and transferred to Immobilon-P for western blot analysis.
Overlay assays
Overlay assays were performed as previously described (34).
Partially purified full-length rat UBF1 protein (200 ng) expressed
in Sf9 cells was separated by SDS–PAGE and transferred to
nitrocellulose membranes. The protein blots were then denatured
in 6 M guanidine–HCl in renaturation buffer (20 mM HEPES,
pH 7.9, 60 mM KCl, 6 mM MgCl2, 0.6 mM EDTA, 2 mM DTT
and 20% glycerol) for 30 min and renatured in 100 mM
guanidine–HCl in renaturation buffer supplemented with 0.02%
polyvinyl pyrolidine twice for 2 h at room temperature. The blots
were then blocked with 3% skim milk in renaturation buffer for
1 h at room temperature. The 35S-labeled rUBF1, xUBF1 and
sxUBF1 were prepared with cDNA templates pCMV-FLAG-
rUBF1, pCMV-FLU-UBF1 and pCMV-FLU-sxUBF1, respectively,
using the Coupled T7 Rabbit Reticulocyte in vitro Transcription
Translation Kit (Promega) supplemented with [35S]methionine.
Equal amounts (∼50 µl) of the 35S-labeled in vitro transcribed
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translated lysates were incubated in 2 ml of renaturation buffer
with the renatured protein blots containing baculovirus UBF, for
16 h at room temperature with gentle shaking. The blots were
washed three times in renaturation buffer containing 200 mM
KCl for 10 min at room temperature, lightly blotted dry and
analyzed on a PhosphorImager.
RESULTS
Overexpression of rat UBF1 drives rDNA transcription
To study the parameters governing ribosomal transcription in vivo
we have constructed several novel polymerase I driven CAT
reporter gene constructs. These contain either the mouse or
Xenopus rDNA promoters and as controls, either a transcriptionally
inactive mouse promoter (–7 G to A) or an inverted Xenopus
promoter (Fig. 1 and Materials and Methods).
As a first step in investigating whether the overexpression of
UBF would be sufficient to drive elevated levels of rDNA
transcription in an immortalized cell line, we examined whether
UBF itself could be overexpressed. Several constructs capable of
driving the expression of rUBF1, rUBF2 and xUBF1 were
assembled (Fig. 1B). Western blotting was carried out to ensure
that the various forms of UBF were expressed equally. NIH3T3
fibroblasts were transfected with either pCMV-rUBF1 (Fig. 1C,
lane 2), or with increasing amounts of pCMV-FLAG-rUBF1
(Fig. 1C, lanes 3–5). After 24 h, whole cell lysates were prepared
from the transfected cells, fractionated by SDS–PAGE, transferred
to Immobilon-P and probed with either an anti-FLAG antibody
(upper panel) or an anti-UBF antibody (lower panel). Transfection
with pCMV-rUBF1 resulted in the overexpression of rUBF1 as
demonstrated by western blotting with anti-UBF antibody (lane 2,
lower panel). As the rUBF1 was not FLAG-tagged it did not react
with the anti-FLAG antibody (lane 2, upper panel). Transfection
with pCMV-FLAG-rUBF1 resulted in the overexpression of
FLAG-tagged rUBF1, as demonstrated by blotting with both
anti-UBF or anti-FLAG antibodies. Similar levels of expression
were detected when the other UBF expression vectors were tested
(e.g. see Fig. 7A).
As the level of expression of UBF1 was proportional to the
amount of DNA used in the transfection, we then examined
whether the level of rDNA transcription would correlate with the
altered cellular content of UBF. In these experiments we first used
pSMECAT, a reporter for rDNA transcription. pSMECAT uses
the mouse rDNA promoter upstream of an IRES to drive the
expression of CAT. Previous efforts to use such reporters have
met with varied degrees of success, as quite often the RPI
promoters, or the constructs themselves, contain cryptic RPII
promoters (35–37). To control for this possibility, we constructed
pSMECAT-7 (Fig. 1). This construct is identical to pSMECAT
except that the G at –7 of the rDNA promoter, essential for
transcription by RPI (1–3), is mutated to an A. Thus, pSME-
CAT-7 should not be transcribed by RPI, and serves as a control
for fortuitous expression from cryptic RPII or even RPIII sites. As
shown in Figure 2A, the level of CAT activity from pSMECAT-7
was <10% of the level of CAT activity supported by the
non-activated pSMECAT (compare the levels of the acetylated
chloramphenicol products in lanes 1 and 5). The residual level of
CAT activity from pSMECAT-7 was also completely unaffected
by the overexpression of UBF (Fig. 2A, lanes 2–4). In contrast,
cotransfection of 3T3 cells with increasing levels of pCMV-
FLAG-rUBF1 resulted in proportionately increasing levels of
CAT activity (Fig. 2A, lanes 5–8). Compilation of the results from
a series of such experiments (Fig. 2B) demonstrated that the
overexpression of UBF1 increased transcription from pSMECAT
by up to 6.5-fold.
The control experiments with pSMECAT-7 provided considerable
assurance that pSMECAT was in fact being transcribed by RPI
and not by RPII. However, this question was further assessed by
determining the site of transcription initiation. RNA was isolated
from cells cotransfected with pSMECAT and pCMV-FLAG-
rUBF1 and the transcription initiation site mapped. As shown in
Figure 2C, S1 nuclease analysis of the RNA obtained from the
transfected cells demonstrated that the site of transcription
initiation was that predicted for transcripts synthesized by RPI.
UBF-dependent activation of transcription is specific to RPI
In combination, the above experiments provided complementary
evidence that pSMECAT is transcribed specifically and predom-
inantly by RPI. However, we were interested to know if UBF
might also have the potential to activate RPII transcription. Cells
were cotransfected with the rDNA reporters and a reporter for
RPII, pSVβ-Gal and both CAT and βGal levels determined. As
shown in Table 1, transcription from pSMECAT, but not
transcription from pSMECAT-7, was stimulated 6-fold when the
3T3 cells were cotransfected with pCMV-FLAG-rUBF1. However,
the absolute β-galactosidase levels measured in each of the
transfections fell within 10% of one another, regardless of the
level of expression of exogenous rUBF. UBF clearly activated
RPI transcription, but did not activate RPII transcription, at least
from the model late SV40 promoter. Thus, UBF appears to be an
RPI specific transcription factor in vivo and maintains this
specificity even when overexpressed. This is consistent with the
exclusive nucleolar localization of the UBF (38,39).
The overexpression of UBF1 can drive an elevated level of
transcription from the endogenous rRNA genes
The above experiments demonstrated that the overexpression of
UBF can significantly activate transcription from a cotransfected
RPI reporter in NIH3T3 cells. As such, they are consistent with
the hypothesis that cells regulate rDNA transcription by modulating
the activity of UBF. However, it was possible that overexpression
of UBF could affect transcription from the reporter but have no
effect on transcription from the endogenous genes.
To examine this question, nuclei isolated from cells cotransfected
with the indicated amounts of pCMV-rUBF1 and pSVβ-Gal
were used in nuclear run-on assays and the levels of rDNA
transcription measured. As shown in Figure 3, the nuclear run-on
assay demonstrated that transfection with pCMV-rUBF1 resulted
in a 2-fold stimulation of endogenous rRNA gene transcription.
A parallel set of plates were stained in situ for β-galactosidase
activity. We found that ∼40% of the cells were transfected. Thus,
overexpression of UBF1 activated transcription from the endo-
genous genes by ∼5-fold (2 × 1/0.4). This was very similar to the
effect of overexpressing UBF on pSMECAT activity. Taken
together, the two sets of results strongly support the hypothesis
that the rate of rDNA transcription is regulated in vivo by the level
of UBF1 within the cell.
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Figure 2. Overexpression of UBF increases transcription from pSMECAT and is initiated at +1. (A) NIH3T3 cells were transfected with the indicated constructs and
the control vector, pSV40βGal, using lipofectamine as described in Materials and Methods. After 24 h, cell lysates were prepared and assayed for CAT activity and
β-galactosidase as described in Materials and Methods. (B) The results from 5–7 separate experiments similar to those in Figure 2A were averaged and adjusted for
the efficiency of transfection. The results are presented as the average fold increase (± SD) in pSMECAT activity in cells cotransfected with increasing amounts of
rUBF expression vector as compared with cells transfected with pSMECAT alone. (C) Total RNAs from control NIH3T3 cells and NIH3T3 cells transfected with
pSMECAT (1 µg) and pCMV-rUBF1 (3 µg), were used in S1 nuclease assays using an end-labeled probe (–150 to +207). After S1 nuclease digestion, the reaction
products from the control (lane 2) and pSMECAT/UBF transfected cells (lane 3) were fractionated by denaturing gel electrophoresis and detected by autoradiography.
Parallel lanes contained the the S1 probe digested with RsaI (cleavage between –1 and +1) and end-labeled fragments of pBR322. The S1 protected fragment showed
an identical mobility with that of the RsaI cleaved probe, while both fragments showed an anomalous migration relative to the HpaII/pBR322 molecular weight marker.
Table 1. UBF activates transcription by RPI, but not by RPII
The overexpression of UBF2 can result in elevated levels of
rDNA transcription
Two previous in vitro investigations have reported that the natural
splice variant UBF2 cannot activate rDNA transcription (22,39). In
our investigation of this problem, we concluded that the low level
of activation by UBF2 seen in in vitro transcription reactions was
probably due to cross contamination of the UBF2 with UBF1 (22).
We investigated this question using the reporter system described
above and vectors, pGAL4-rUBF1 and pGAL4-rUBF2, that
expressed full-length UBF1 and UBF2 tagged with the DNA-
binding domain of Gal4. As shown in Figure 4, cotransfection of
3T3 cells with pSMECAT and increasing amounts of pGAL4-
rUBF1 resulted in dose-dependent activation of transcription from
pSMECAT that was very similar in level to that seen with the other
rUBF expression vectors. Interestingly, cotransfection with pSME-
Figure 3. Overexpression of UBF1 stimulates transcription of the endogenous
ribosomal genes in NIH3T3 cells. NIH3T3 cells were transfected with
pCMV-rUBF (1 µg/60 mm dish) as described in Materials and Methods, nuclei
were isolated, and ribosomal DNA transcription was measured as described in
Materials and Methods. Radiolabeled rRNA transcripts were purified from the
reaction mix, and hybridized to 45S rDNA (clone pU5.1E/X) or control pUC
19 DNA. After stringent washes, the hybrids were visualized by autoradiography
(see autoradiogram). The radioactivity of 45S run-on transcripts obtained from
three separate experiments were quantified by laser densitometry and are
presented as the average percentage increase ± SD in rDNA transcription in
response to contraction over the transcription observed in contraction-arrested
cells. *, denotes significance from control cells (P < 0.01)
 at A
ustralian N
ational U
niversity on February 1, 2016
http://nar.oxfordjournals.org/
D
ow
nloaded from
 
 Nucleic Acids Research, 1999, Vol. 27, No. 41210
Figure 4. UBF2 is only one third as active as UBF1 at transactivating the rDNA
promoter in vivo. NIH3T3 cells were transfected with increasing amounts of
pSV40-rUBF1 or pSV40-rUBF2 (0.5–1 µg/60 mm dish) and pSMECAT (1 µg/60
mm dish). After 24 h, cell lysates were prepared and assayed for CAT activity and
β-galactosidase as described in Materials and Methods. The results from 3–4
separate experiments were averaged and adjusted for the efficiency of transfection.
The results are presented as the average fold increase (± SD) in pSMECAT activity
in cells cotransfected with increasing amounts of rUBF1 or rUBF2 expression
vector as compared with cells transfected with pSMECAT alone.
CAT and increasing amounts of pSV40-GAL4-rUBF2 also resulted
in a dose-dependent activation of transcription from pSMECAT
(Fig. 4). However, the maximum level of activation achieved using
pGAL4-rUBF2 was only 30% of that observed using pGAL4-
rUBF1 (compare the relative CAT activity levels when cells are
cotransfected with pSMECAT and 1 µg of either pGAL4-rUBF1 or
pGAL4-rUBF2). These results suggest that UBF2 is not as effective
as UBF1 in activating rDNA transcription. Nonetheless, UBF2 does
exhibit some activation potential. This result in fact agrees with our
previous in vitro observation showing that UBF2 was 30% as active
as UBF1 and suggests that the level of in vitro activation observed
in those experiments reflected the true activity of UBF2.
UBF anti-sense RNA inhibits transcription from pSMECAT
The above studies demonstrated that artificially raising the cellular
content of UBF results in a stimulation of rDNA transcription. We
were also interested in determining if a reduction in the cellular
content of UBF would result in a decrease in the level of basal
rDNA transcription. To test this, a plasmid was constructed to
express the antisense strand of the first 440 bp of rUBF,
pCMV5-rUBF440(-). Cotransfection of NIH3T3 cells with
pSMECAT (1 µg) and increasing amounts of pCMV-rUBF440-
(0.5–2 µg) resulted in decreasing levels of CAT activity (Fig. 5,
upper panel). Compilation of the results from a series of such
experiments (Fig. 5, lower panel) demonstrated that the antisense
UBF construct (2 µg) decreased basal transcription from
pSMECAT by up to 75%.
The overexpression of Xenopus UBF1 results in elevated
levels of transcription from the mouse rDNA reporter in
murine cells
Transcription of vertebrate ribosomal RNA genes is species-specific
(1–3). One clear demonstration of this property is the inability of
active extracts of human cells to transcribe the rat and mouse rDNAs
Figure 5. Overexpression of antisense UBF inhibits rDNA transcription.
(A) NIH3T3 cells were transfected with increasing amounts of a construct that
expresses antisense rUBF, pCMV-rUBF440- and pSMECAT. After 24 h, cell
lysates were prepared and assayed for CAT activity and β-galactosidase as
described in Materials and Methods (upper panel). (B) The results from 3–4
separate experiments similar to that presented in Figure 7A were averaged and
adjusted for the efficiency of transfection and presented graphically. The results
are the average-fold increase (± SD) in pSMECAT activity in cells cotransfected
with increasing amounts of pCMV-rUBF1440- expression vector as compared
with cells transfected with pSMECAT alone. (* and **, denote statistically
significant differences from control values of P < 0.05 and P, 0.01, respectively.)
A.
B.
in vitro (e.g. 12). This species specificity has predominantly been
ascribed to the TBP-containing rDNA transcription factor
referred to as SL-1 (12). It has also been shown that the structural
differences between the mammalian and amphibian UBFs may
represent a further level of species specificity. However, species-
specific UBF activity has been noted only under certain precise
conditions of protein and template concentration in vitro. Under
other conditions the mammalian and Xenopus forms of UBF
appear equivalent (18,40).
We investigated the role of UBF in species specificity in an in
vivo context. We first determined if xUBF and rUBF could
heterodimerize, and then determined the effect of xUBF on rDNA
transcription in vivo. Vectors were constructed that would direct
the expression of FLU-tagged forms of either rUBF1 or xUBF1,
(pCMV-FLU-rUBF1 and pCMV-FLU-xUBF1). A third vector
was created to express a rat–Xenopus UBF chimera, r/xUBF1, in
which the sequences of rUBF1 HMG-box 4 had been replaced with
the equivalent HMG-box-less region of xUBF1. In addition, as a
control for the expression of xUBF, a vector that would express a
mutant of xUBF lacking the NH2-terminal dimerization domain was
constructed, pCMV-FLU-sxUBF1. It has been reported that UBF
lacking the NH2-terminal domain is unable to dimerize and cannot
activate rDNA transcription in vitro (1,2,41,42).
As shown in Figure 6A, overlay assays demonstrated that
rUBF1 and xUBF1 can both homo- and heterodimerize and
confirmed that sxUBF1 was unable to heterodimerize with
rUBF1 (and by inference cannot therefore homodimerize). The
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ability of xUBF to heterodimerize with rUBF was also examined in
vivo (Fig. 6B). NIH3T3 cells were transiently transfected with either
the ‘empty’ expression vector pCDNA3 (lane 1), pCMV-Flu-xUBF
(lane 2) or a combination of pCMV-Flu-xUBF1 and pCMV-FLAG-
rUBF (lane 3). Following transfection, whole cell lysates were
prepared and UBF complexes were immunoprecipitated using
anti-UBF antibodies or anti-FLAG antibodies. The immuno-
precipitated proteins were resolved by SDS–PAGE, transferred to
nylon membranes and blotted with either anti-FLU, anti-FLAG or
anti-UBF antibodies. Antibodies to rat UBF immunoprecipitated
both wild-type rUBF and also FLAG-tagged rUBF (Fig. 6B,
lanes 4 and 5). FLU-tagged xUBF was also immunoprecipitated
(lane 6). Control experiments demonstrated that our antibodies to
rat UBF do not immunoprecipitate Xenopus UBF. Thus, the
Flu-tagged xUBF can only have been coimmunoprecipitated if it
was heterodimerized with rUBF. Similarly, anti-FLAG antibodies
immunoprecipitated both FLAG-tagged rUBF and Flu-tagged
xUBF. In this case, the FLU-tagged xUBF could only have been
coprecipitated with the FLAG tagged rUBF if it was in the form of
a Flu-xUBF/rUBF-FLAG heterodimer. These studies demonstrate
that xUBF and rUBF can heterodimerize both in vitro and in vivo
and confirm that deletion of the NH2-terminal domain of xUBF
prevents this dimerization.
We then compared the effects of overexpressing FLU-xUBF
and FLU-rUBF on transcription from pSMECAT. Western blots
of extracts from cells transfected with 0.5 µg of either pCMV-
FLU-rUBF1, pCMV-FLU-xUBF1 or pCMV-FLU-sxUBF1
demonstrated that the three vectors supported approximately
equal levels of expression of the three FLU-tagged proteins
(Fig. 7A). Similar expression levels were also observed for the
mammalian–Xenopus UBF chimera, r/xUBF1 (results not
shown). Cotransfection of 3T3 cells with pSMECAT and
pCMV-FLU-rUBF1 resulted in a maximum level of activation of
6.3-fold (Fig. 7B). Interestingly, when cells were cotransfected
with pSMECAT and pCMV-FLU-xUBF1, the maximum level of
activation of 6.1-fold was very similar. Furthermore, a very similar
level of activation was also seen when the r/xUBF chimera was over
expressed with pSMECAT, (Fig. 7B). Transfection of NIH3T3 cells
with pSMECAT and pCMV-Flu-sxUBF1 resulted in a weak, but
not statistically significant, activation (Fig. 7B). These results
demonstrate that Xenopus UBF1 can activate transcription from
a mouse rDNA promoter in a mouse cell line. Interestingly, when
the Xenopus rDNA reporter was used in the same experiments,
we did not observe transcription from the Xenopus promoter
either in the absence or in the presence of exogenous rUBF1 or
xUBF1 (Fig. 7C). pXECAT has been shown to direct CAT
expression in X.laevis cells (data not presented). These results
argue that in vivo, the activity of UBF is not species-specific and
further that the appropriate UBF cannot abrogate the need for the
homologous form of SL-1.
DISCUSSION
The transcription of the ribosomal RNA genes is a process
essential for cell growth. Not only is it known to be regulated in
response to growth rate changes but it may also represent a means
of regulating long term growth. Despite this, little or nothing is
known of the manner in which the ribosomal RNA genes are
regulated. Here we present the first demonstration that the
ribosomal transcription factor UBF is functionally limiting for
RPI transcription in NIH3T3 fibroblasts. We show that the
Figure 6. Xenopus UBF1 dimerizes with rat UBF in vitro and in vivo.
(A) Full-length xUBF1 but not xUBF1 missing the NH2 terminal domain
dimerizes with rat UBF. Full-length rat UBF1 protein (500 ng) purified from
Baculovirus (pVL1393) was separated by SDS–PAGE and transferred to
nitrocellulose membranes. The protein blots were then denatured and renatured
as described in Materials and Methods. After blocking with 3% skim milk in
renaturation buffer for 1 h at room temperature, the membranes were incubated
in 2 ml or renaturation buffer containing S35-labeled in vitro transcribed
translated rUBF1, xUBF1 or sxUBF1 for 16 h at room temperature with gentle
shaking. The blots were washed three times in renaturation buffer containing
200 mM KCl for 10 min at room temperature, lightly blotted dry and analyzed
on a PhosphorImager. The experiments were repeated three times and typical
images are shown. (B) xUBF dimerizes with rUBF in vivo. NIH3T3 cells were
transfected with either pCMV, pCMV-FLU xUBF1 or a combination of
pCMV-FLU-xUBF and pCMV-FLAG-rUBF. After 24 h, cell lysates were
prepared and the UBF proteins immunoprecipitated with anti-rUBF antibodies or
anti-FLAG antibodies. The immunoprecipitated proteins were fractionated by
SDS–PAGE, transferred to Immobilon-P and blotted with the described antibodies.
activity of a novel CAT reporter construct, pSMECAT, whose
expression is driven by the mouse RPI promoter, depends directly
on the cellular level of UBF. We demonstrate that overexpression
of UBF leads to a dose dependent activation, up to 6.5-fold, of the
reporter gene and that cotransfection of an antisense UBF
construct suppresses reporter activity. This is the first observation
of the dependence of mammalian ribosomal transcription on a
known transcription factor in vivo. The observation is all the more
significant since we also show that the endogenous ribosomal
genes can be activated by increasing the cellular concentration of
UBF. Thus, the reporter construct pSMECAT appears to provide
a model system that closely reflects endogenous ribosomal
transcription regulation. We further show that activation of
transcription by UBF is specific to RPI transcription. It is
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Figure 7. Overexpression of Xenopus UBF1 results in elevated levels of
transcription from the mouse rDNA reporter in NIH3T3 cells. (A) pCMV-Flu-
rUBF1, pCMV-FLU-xUBF1 and pCMV-sxUBF1 are expressed at similar
levels in NIH3T3 cells. Twelve hours after transfection with pCMV-Flu-UBF1
(lane 1, 2 µg), pCMV-Flu-xUBF1 (lane 2, 2 µg) or pCMV-Flu-sxUBF1 (lane
3, 2 µg), nuclear proteins were isolated, fractionated by SDS–PAGE and blotted
to nylon membranes. Recombinant Flu-Tagged UBF was detected with a
monoclonal anti-Flu as described in Materials and Methods. (B) r/xUBF1 and
xUBF1 but not sxUBF drive transcription from pSMECAT. NIH3T3 cells were
transfected with the indicated amounts of the described constructs and pCMVβ.
After 24 h, cell lysates were prepared and assayed for CAT activity and
β-galactosidase as described in Materials and Methods. The results from 3–4
separate experiments were averaged and adjusted for the efficiency of
transfection and presented graphically. The results are the average-fold increase
(± SD) in pSMECAT activity in cells cotransfected with increasing amounts of
the indicated UBF expression constructs compared with cells transfected with
pSMECAT alone. (C) Overexpression of Xenopus UBF1 does not drive
transcription form the Xenopus rDNA promoter in murine cells. NIH3T3 cell were
transfected with the indicated UBF expression constructs (1 and 2 mg/60 mm dish)
and either pSMECAT-7, pSMECAT, pXECAT or piXECAT (1 µg/60 mm dish) as
described in Materials and Methods. Twenty-four hours following transfection
cell lysates were prepared and assayed for CAT activity as described in
Materials and Methods.
concluded that the cellular level of UBF is a potential regulator of
ribosomal gene transcription, a view consistent with the several
observations of growth regulated UBF expression (reviewed in 43).
Ribosomal transcription is species-specific, the human promoter
does not function in mouse and neither the human nor the mouse
promoters function in Xenopus (1–3). Though it is clear that this
specificity resides predominantly with the TBP-complex SL-1, in
vitro experiments have also suggested that some degree of species
specificity exists at the level of UBF (16). We clearly show,
however, that in vivo there exists no significant difference in the
capacity of rat or Xenopus UBF to activate RPI transcription. On
the other hand, in confirmation of in vitro data, we show that the
xUBF cannot abrogate the need for the cognate SL-1, since the
Xenopus rDNA promoter remains silent in NIH3T3 cells even in
the presence of excess xUBF1. Furthermore, we show that the
activity of xUBF depends on its ability to dimerize, strongly
suggesting that the predominant mode of activation by the UBFs
in vivo is mediated by their ability to bind DNA (19,41). In
support of this conclusion, we have more recently shown that
single point mutations that effect DNA binding by xUBF also
lead to a similar loss of activation (V.Stefanovsky and R.Hannan,
unpublished data). It is possible that a secondary role of UBF
could be to indirectly activate transcription by squelching
repressors (15) of ribosomal transcription such as Rb (44,45).
Indeed, sxUBF does show a residual level of activation that could
be explained by such an effect and this conclusion is consistent
with the observed activity of rUBF2, discussed below.
Though natural splice variants of UBF occur in all systems
studied to date, no function for these variants has yet been
described. In mammals the second HMG-box DNA binding
domain is missing in the UBF2 splice variant. In vitro studies have
suggested that UBF2 is non-functional in transcription activation
and that its affinity for DNA is greatly reduced as compared with
UBF1 (22,39). Using the RPI reporter we have tested the in vivo
role of UBF2 in ribosomal transcription and find that in fact it
does activate transcription, but only ∼30% as well as UBF1. This
level of activation is in fact similar to the residual levels of
activation seen with the NH2-terminal deletion mutant sxUBF
and point mutants of xUBF1, (data not shown), all of which are
also compromised in DNA binding. This suggests that part of the
function through which UBF acts may squelch the action of a
repressor such as Rb (46,47) and that this is the only part of the
mechanism through which UBF2 may act.
How then might UBF function in regulating the ribosomal
genes? UBF is able to form an alternative chromatin based on the
ribosomal enhancesome. The enhancesome resembles a nucleosome
in terms of total DNA and protein content, but differs in that a
dimer of UBF replaces the histones and the DNA component is
wound into a single not into a double loop as it would be in the
nucleosome (48,49). In vitro studies show that the interaction of
UBF with SL-1 and the rDNA promoter facilitates, but may not
be necessary for, the formation of the RPI initiation complex
(12,50). Hence, in vivo the availability of UBF may regulate the
number of genes actively engaged in transcription via a direct
gene interaction. In any given cell the number of potentially
active ribosomal genes generally represents only a fraction of the
total gene number. In yeast, this fraction is regulated in response
to growth rate changes as demonstrated by psoralen crosslinking
(51). Interestingly, the fraction of potentially active/active
ribosomal genes (versus inactive genes) does not appear to
change in a given mammalian cell as measured by the same
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technique (52). If the chromatin structure is not different between
active and potentially active ribosomal genes, perhaps it is the
association of UBF with a gene which determines that it may be
active. Interestingly, the number of visible nucleoli (i.e. the
number of active ribosomal gene loci or active nucleolar
organizers) has also long been recognized as a measure of tumor
cell growth rate (e.g. 53,54).
Psoralen probes the chromatin state of the ribosomal genes,
inactive and active (or potentially active) loci showing significantly
different accessibilities. This difference could represent a switch
in chromatin structure between the repressed nucleosomal state
and the enhancesome structure (UBF–DNA). Estimates of UBF
concentration are quite variable, but suggest that sufficient UBF
exists within the cell to engage not only the promoter but also a
large segment of the intergenic spacer including the enhancer rDNA
elements of the active ribosomal genes (recent measurements
demonstrate 200 000 copies/3T3 cell; L.Rothblum and
A.H.Cavanaugh, unpublished observation). The observation that
the DNA-binding-mediated activity of UBF is limiting for
ribosomal gene activity is consistent with its potential to induce
a structural change in ribosomal gene chromatin and hence its
ability to recruit genes to the active pool.
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